-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.P1.63 905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, Coronaviruses, CRS, Leukemia, multiple myeloma, SARS-CoV-2/COVID-19, survivorship, bioengineering, Bleeding and Clotting, CLL, Diseases, Lymphoma (any), Marginal Zone Lymphoma, neurotoxicity, Non-Biological, CAR-Ts, Combinations, Elderly, Mantle Cell Lymphoma, Therapies, Adverse Events, chemotherapy, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, Biological Processes, DLBCL, Thrombosis, immune cells, Technology and Procedures, Young Adult, Cell Lineage, immunotherapy, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, Quality Improvement , multi-systemic interactions
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Vaishali Sanchorawala, MD1, Giovanni Palladini, MD, PhD2, Monique C. Minnema3, Arnaud Jaccard, MD, PhD4*, Hans C. Lee, MD5, Simon D. Gibbs, FRACP, FRCPA, MBBS6*, Peter Mollee, FRACP, MBBS, MSc, FRCPA7, Christopher P. Venner, MD8, Jin Lu9, Stefan Schönland, MD10*, Moshe Gatt, MD11, Kenshi Suzuki, MD, PhD12, Kihyun Kim, MD13*, M. Teresa Cibeira, MD, PhD14*, Meral Beksac, MD15, Edward Libby, MD16, Jason Valent, MD17, Vania T. M. Hungria, MD, PhD18, Sandy W. Wong, MD19, Michael Rosenzweig, MD20, Naresh Bumma, MD21, Dominique Chauveau, MD, PhD22*, Katharine S. Gries, PhD, PharmD23*, John Fastenau, RPh, MPH, PhD23*, NamPhuong Tran, MD24*, Xiang Qin, MD, PhD24*, Sandra Y. Vasey, MSc24*, Brenda Tromp, MSc25, Brendan M. Weiss, MD24*, Jessica Vermeulen, MD, PhD26, Giampaolo Merlini, MD27*, Raymond L. Comenzo, MD28, Efstathios Kastritis, MD29* and Ashutosh D. Wechalekar, MBBS, FRCP, FRCPath, DM30

1Section of Hematology and Oncology, Boston Medical Center and Boston University School of Medicine, Boston, MA
2Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
3University Medical Center Utrecht, Utrecht, Netherlands
4CHU de Limoges - Fédération Hépatologie, Limoges, France
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6Box Hill Hospital, Box Hill, Australia
7Princess Alexandra Hospital, Woolloongabba, Australia
8Alberta Health Services, Edmonton, AB, Canada
9Peking University People's Hospital, Beijing, China
10Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg, Germany
11Hadassah Medical Center, Jerusalem, Israel
12Department of Hematology, Japanese Red Cross Central Medical Center, Tokyo, Japan
13Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
14Hospital Clinic of Barcelona, Barcelona, Spain
15Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, Ankara, Turkey
16Seattle Cancer Care Alliance, Seattle, WA
17Cleveland Clinic, Cleveland, OH
18São Germano Clinic, São Paulo, Brazil
19University of California, San Francisco, San Francisco, CA
20City of Hope, Duarte, CA
21The Ohio State University, Columbus, OH
22CHU Rangueil, Toulouse, France
23Janssen Research & Development, LLC, Raritan, NJ
24Janssen Research & Development, LLC, Los Angeles, CA
25Janssen Research & Development, LLC, Leiden, Netherlands
26Janssen Research & Development, LLC, Leiden, CB, Netherlands
27Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
28Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
29Alexandra General Hospital of Athens, Athens, Greece
30University College Hospital, London, United Kingdom

Lucia D Notardonato, MD1, Spencer S Langerman, PhD2*, Brian C.-H. Chiu, PhD2 and Benjamin A Derman, MD3

1Section of General Internal Medicine, University of Chicago, Chicago, IL
2Department of Public Health Sciences, University of Chicago, Chicago, IL
3Section of Hematology/Oncology, University of Chicago, Chicago, IL

Sarah S. Makhani, BA, Dana Shively, BS*, Grettel Castro, MPH*, Pura Rodriguez, MPH* and Noël C. Barengo, MD, PhD, MPH*

Florida International University, Herbert Wertheim College of Medicine, Miami, FL

Jennifer M Knight, MD MS1*, Igli Arapi, MSc2*, Aniko Szabo, PhD2*, Sharon Yim, BS2*, Garrett Sauber, BS2*, Cecilia Hillard, PhD2*, Parameswaran Hari, MBBS, MD3 and Nirav N. Shah, MD4

1Medical College of Wisconsin, Milwaukee
2Medical College of Wisconsin, Milwaukee, WI
3CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI

John L Vaughn, MD1, Laura C Pinheiro, PhD, MPH2* and Narendranath Epperla, MD, MS3

1Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
2Division of General Internal Medicine, Weill Cornell Medicine, New York, NY
3The Ohio State University James Comprehensive Cancer Center, Columbus, OH

Emilie D Duchesneau, BA1*, Annie M McNeill, PhD2*, Jerzy E Tyczynski, PhD2*, William Schary, PhD2 and Jennifer L Lund, PhD1*

1Department of Epidemiology, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, NC
2AbbVie, North Chicago, IL

Julia Thornton Snider, PhD1*, Paul Cheng, MD, PhD1, Xue Song, PhD2*, Donna McMorrow2* and David Diakun2*

1Kite, A Gilead Company, Santa Monica, CA
2IBM Watson Health, Cambridge, MA

Anna Eversman1*, Shufen Cao1*, Kirsten M Boughan, DO2, Molly M Gallogly, MD, PhD2, Ehsan Malek, MD3, Leland Metheny III, MD2, Timothy E. O'Brien, MD2, Folashade Otegbeye, MBBChir, MPH2, Brenda W. Cooper, MD2, Pingfu Fu1*, Marcos de Lima, MD2 and Paolo F Caimi, MD2

1Case Western Reserve University, Cleveland, OH
2Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
3Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Hts, OH

Hira S Mian, MD1, Gregory R Pond, PhD, PStat1*, Tanya M. Wildes, MD, MSc2, Branavan Sivapathasundaram, MSc3*, Jonathan Sussman, MD, FRCPC, MSc4* and Hsien Seow, PhD4*

1Department of Oncology, McMaster University, Hamilton, ON, Canada
2Washington University, Saint Louis, MO
3McMaster University, Hamilton, ON, Canada
4Oncology, McMaster University, Hamilton, ON, Canada

Rahul Banerjee, MD1, Ann Lazar, PhD, MS1*, Lisa Dunn, RN1*, Jennifer Knoche, RN1*, Kelly Jean Brassil, PhD, MA, MSN, RN2, Dhiren Patel, PharmD2*, Lindsey Jackson, MPH, CPH2*, Mimi Lo, PharmD, BCPS, BCOP3*, Anand Dhruva, MD4*, Shagun Arora, MD1, Sandy W. Wong, MD5, Jeffrey L. Wolf, MD1, Thomas Martin III, MD1 and Nina Shah, MD6

1University of California, San Francisco, San Francisco, CA
2Pack Health, Birmingham, AL
3Department of Pharmaceutical Services, University of California, San Francisco, San Francisco, CA
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
5Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
6Associate Professor of Medicine, University of California San Francisco, San Francisco, CA

Michael Roderick Cook, MD1*, Kaitlyn C Dykes, MD, BS2, Katherine White3*, Jaeil Ahn, PhD4*, Nathan Cobb, MD5* and Catherine Lai, MD, MPH1

1Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
2Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC
3Georgetown University School of Medicine, Washington, DC
4Georgetown University, Department of Biostatistics, Bioinformatics, and Biomathematics, Washington D.C.
5Division of Pulmonary, Critical Care, and Sleep Medicine, MedStar Georgetown University Hospital, Washington, DC

Jipan Xie, MD, PhD1*, Aozhou Wu, PhD1*, Laura Liao, MS2*, Xiaoyan Du, MESc1*, Ahmed Noman, BA1*, Yawen Liang, PhD1*, Joseph Camardo, MD2* and Lei Chen, MD, PhD2*

1Analysis Group, Inc., Los Angeles, CA
2ADC Therapeutics, Inc., New Providence, NJ

Hyery Kim, MD1, Hae Reong Kim2* and Yu Rang Park2*

1Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Korea, Republic of (South)
2Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)

Nina Shah, MD1, Dieter Ayers2*, Faith E. Davies3, Shannon Cope2*, Ali Mojebi2*, Kejal Parikh4*, Devender Dhanda4*, Parameswaran Hari, MBBS, MD5, Payal Patel4*, Liping Huang, PhD4*, Kristen Hege4 and Sujith Dhanasiri6*

1Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
2PRECISIONheor, Vancouver, BC, Canada
3Perlmutter Cancer Center, NYU Langone Health, New York, NY
4Bristol Myers Squibb, Princeton, NJ
5Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
6Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland

Carla Casulo, MD1, Tanzy Love, PhD2*, Xiang Lu, PhD2*, Melissa C. Larson, MS3*, Kathleen J. Yost, PhD4*, Allison C. Rosenthal, D.O.5, Thomas M. Habermann, MD6, Brian K. Link, MD7, Andrew L. Feldman, MD8, Susan L. Slager, PhD4*, Jonathon B. Cohen, MD, MS9, Christopher Flowers, MD, MS10, James R. Cerhan, MD, PhD6 and Carrie A. Thompson, MD6

1Department of Medicine , Hematology/Oncology, James P. Wilmot Cancer Center, Rochester, NY
2Department of Biostatistics, University of Rochester, Rochester, NY
3Bistatistics, Mayo Clinic, Rochester, MN
4Department of Health Sciences Research, Mayo Clinic, Rochester, MN
5Mayo Clinic, Phoenix, AZ
6Division of Hematology, Mayo Clinic, Rochester, MN
7Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
9Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
10MD Anderson Cancer Center, Houston, TX

Katja Weisel, MD1*, Ajay Nooka, MD, MPH2, Evangelos Terpos, MD, PhD3, Andrew Spencer4, Hartmut Goldschmidt, MD5, Istvan Majer, PhD6*, Lucy DeCosta, MSc7*, Rohan Medhekar, PhD8*, Akeem Yusuf, PhD, BPharm8* and Shaji K. Kumar, MD9

1Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
3Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
4Australian Centre for Blood Diseases, Myeloma Research Group, Alfred Hospital, Monash University, Melbourne, Australia
5Internal Medicine V and National Center for Tumor Diseases, University Clinic Heidelberg, Heidelberg, Germany
6Economic Modeling CoE, Pricing and Access CoE, Global Value and Access, Amgen (Europe) GmbH, Rotkreuz, Switzerland
7Global Biostatistical Science, Amgen Ltd, Uxbridge, United Kingdom
8Amgen, Inc., Thousand Oaks, CA
9Division of Hematology, Mayo Clinic, Rochester, MN

Esther R. Berko, MD1*, Yahui Wei2*, Emily Stiglich1*, Derek Klingman2*, Julie Vardaro2*, Sarah K Tasian, MD3, Sara McDonough, CRNP1*, Katelyn Oranges, CRNP1*, Kelly Meyers, CRNP1*, Eileen Aber, CRNP1*, Miriam Kolb, CRNP1*, Lindsay Borel4*, Nicholas Evageliou, MD3*, Rebecca Citrin, MD3*, Jane Minturn, MD, PhD3*, Anne Reilly, MD3* and Susan R. Rheingold, MD3

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Quality and Safety, Children's Hospital of Philadelphia, Philadelphia, PA
3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
4Division of Childlife, Children's Hospital of Philadelphia, Philadelphia, PA

Liat Vidal1*, Anthony J Messina, MSc2,3, Laura Vidal, MD4*, Vasily Andrianov, MD5, Kelly K. Curtis, MD6 and Keren R. Moss, MD7*

1Syneos Health, Tel Aviv, Israel
2Oncology Hematology, Syneos Health, St. Lucie, FL
3George Washington University, Port St Lucie, FL
4Syneos Health, Barcelona, Spain
5Oncology Hematology, Syneos Health, San Jose, CA
6Syneos Health, Tampa, FL
7Syneos Health, Midreshet Ben Gurion, Israel

S Nikiforow, MD, PhD1, Robert Baiocchi, MD, PhD2, S Nasta, MD3, W-K Weng, MD, PhD4, D Loeb5*, K M Mahadeo, MD6, J Whangbo, MD, PhD1, P Phuong7*, W Navarro, MD7, L Gamelin7*, Y Sun, PhD8*, N Guzman-Becerra8* and S Prockop, MD9

1Dana-Farber Cancer Institute, Boston, MA
2OSU James Cancer Hospital, Columbus, OH
3University of Pennsylvania, Philadelphia, PA
4Division of Blood and Marrow Transplantation, Dept. of Medicine, Stanford Univ. School of Med., Stanford, CA
5Children’s Hospital at Montefiore, Bronx, NY
6MD Anderson Cancer Center, Houston, TX
7Atara Biotherapeutics, South San Francisco, CA
8Atara Biotherapeutics, Thousand Oaks, CA
9Memorial Sloan Kettering Cancer Center, New York, NY

Lauren Willis, PharmD, BCOP1, Tristin Abair, PhD2* and Sara R. Fagerlie, PhD, CHCP2

1Medscape Education, LLC, Lexington, KY
2Medscape Education, LLC, New York, NY

Jing-Zhou Hou, MD, PhD1, Kellie Ryan, MPH2*, Senxi Du3*, Bruno S. Fang, MD4, Stanley M. Marks, MD1, Ray Page5,6*, Eileen Peng, PharmD4*, Keith Szymanski2*, Sharon Winters1* and Hannah Le, PharmD, MPH2*

1University of Pittsburgh Medical Center, Pittsburgh, PA
2AstraZeneca, Gaithersburg, MD
3Keck School of Medicine, Los Angeles, CA
4Regional Cancer Care Associates, East Brunswick, NJ
5The Center of Cancer and Blood Disorders, Fort Worth, TX
6Quality Cancer Care Alliance Network, Tacoma, WA

Matthew C. Cheung, MD, MSc1, Irina Amitai, MD2* and Jiajia Liu, MD3

1Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
2Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
3University of Toronto, Toronto, ON, Canada

*signifies non-member of ASH